Discover and read the best of Twitter Threads about #MiltonPacker
Most recents (2)
Is it important for physicians to understand mechanisms to treat heart failure? By Legendary #MiltonPacker
@HFA_President @WilfriedMullens @FH_Verbrugge @JavedButler1
@jozinetm @_antocannata @DjawidHashemi
@doctorchecho @h_arfsten
@SotiriaLiori @LauraMeems @escardio
@HFA_President @WilfriedMullens @FH_Verbrugge @JavedButler1
@jozinetm @_antocannata @DjawidHashemi
@doctorchecho @h_arfsten
@SotiriaLiori @LauraMeems @escardio
Physicians make decisions NOT by memorizing trials or guidelines, but by having a conceptual framework about drugs and diseases
#HeartFailure2023 @ESC_Journals @escardio @WilfriedMullens @HFA_President @ARakisheva @FH_Verbrugge @WilfriedMullens
#HeartFailure2023 @ESC_Journals @escardio @WilfriedMullens @HFA_President @ARakisheva @FH_Verbrugge @WilfriedMullens
How Physician Thinking and Decision-Making Is Supposed to Work
Dr. #MiltonPacker proved it in these 4 slides
#HeartFailure2023 @HFA_President @JavedButler1 @MarcoMetra @gcfmd @mmamas1973 @pabeda1 @WilfriedMullens @ESC_Journals
Dr. #MiltonPacker proved it in these 4 slides
#HeartFailure2023 @HFA_President @JavedButler1 @MarcoMetra @gcfmd @mmamas1973 @pabeda1 @WilfriedMullens @ESC_Journals
In patients with #HFpEF, treatment with #empagliflozin improves clinical outcomes regardless of background #MRA therapy
jacc.org/doi/10.1016/j.…
@JACCJournals #JACC @unic_cardiovasc @JavedButler1 @FaiezZANNAD #MiltonPacker @robmentz @BiykemB @HFpEF @ShelleyZieroth
jacc.org/doi/10.1016/j.…
@JACCJournals #JACC @unic_cardiovasc @JavedButler1 @FaiezZANNAD #MiltonPacker @robmentz @BiykemB @HFpEF @ShelleyZieroth
#MRAs were used in 37% of EMPEROR-Preserved study participants. MRA use was higher in those with a more congested clinical picture, with more HF🏥 within the past 12 months, worse HF symptoms, mildly reduced EF, higher NT-proBNP levels, and more use of loop diuretic agents
The effect of empagliflozin to reduce HF 🏥 was more pronounced in MRA nonusers than in MRA users, particularly in the subgroup of patients with LVEFs ≥50% @HFpEF @DrRyanPDaly @AndrewJSauer @AnastasiaSMihai @DrMarthaGulati @ErinMichos @ShelleyZieroth @mvaduganathan
